GlassScriptPhysician profile
Madison B Webb
NPI 1013409978
$3,504.69
in general payments reported to CMS, 2019-2025
25 companies · $689 in 2025
The $689 reported for 2025 was more than what 92% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $488 · 2022: $526 · 2023: $958 · 2024: $844 · 2025: $689.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,491.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $716.18 | 2021-2024 | |
| Novo Nordisk INC | $435.86 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Exeltis, USA INC. | $409.54 | 2021-2024 | Slynd |
| Mayne Pharma Commercial LLC | $298.35 | 2022-2025 | |
| Millicent US INC | $232.60 | 2023-2025 | Intrarosa, Femlyv |
| Biogen, INC. | $223.92 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $169.00 | 2021-2025 | Veozah |
| Evofem Biosciences, INC. | $168.43 | 2021-2025 | Phexxi, Solosec, Phexx |
| Innovation Technologies INC | $131.75 | 2024 | Irrisept |
| Therapeuticsmd, INC. | $110.23 | 2021-2022 | |
| Hologic Sales and Service, LLC | $101.38 | 2022-2023 | Aptima, Novasure |
| Axonics, INC. | $99.70 | 2023 | Axonics, Bulkamid |
| Avion Pharmaceuticals | $65.76 | 2021-2023 | Balcoltra |
| Shield Therapeutics INC | $62.78 | 2024 | |
| Organon LLC | $51.25 | 2024 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $50.30 | 2022 | |
| Coloplast Corp | $30.41 | 2025 | |
| Aspira Women'S Health INC | $24.55 | 2024 | Ova1 |
| Lilly USA, LLC | $23.84 | 2024 | Zepbound |
| Sumitomo Pharma America, INC. | $18.07 | 2024 | Myfembree |
| Acella Pharmaceuticals, LLC | $17.89 | 2025 | NP Thyroid 60 |
| Currax Pharmaceuticals LLC | $17.28 | 2022 | |
| Mylan Pharmaceuticals INC. | $17.19 | 2021 | |
| Exact Sciences Corporation | $14.52 | 2023 | Cologuard Collection Kit |
| Idorsia Pharmaceuticals US INC | $13.91 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madison Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.